Avantor to acquire Masterflex for $2.9B

By The Science Advisory Board staff writers

September 7, 2021 -- Avantor has agreed to purchase the Masterflex bioprocessing business and related assets of Antylia Scientific in an all-cash deal valued at $2.9 billion.

The purchase will strengthen Avantor's offering across all bioproduction platforms, including monoclonal antibodies, cell and gene therapy, and mRNA, according to the company. It will also support manufacturing of both therapies and vaccines.

Masterflex manufactures peristaltic pumps and aseptic single-use fluid-transfer technologies. Its 2022 revenues are estimated to top approximately $300 million.

The net purchase price is expected to be $2.7 billion due to anticipated tax benefits from the transaction structure, Avantor said. Subject to customary closing conditions and applicable regulatory approvals, the deal is expected to be completed in the fourth quarter of 2021 and accretive to adjusted earnings per share within one year.

Avantor invests in global hydration capabilities
Avantor has completed a major expansion of its European manufacturing facility in Gliwice, Poland, as part of a multiyear investment in its global hydration...
Avantor increases manufacturing of single-use technology
Avantor plans to increase its manufacturing capability of single-use technologies for biologics and vaccines.
Avantor to acquire liquid handling manufacturer Ritter for $1B
Avantor has entered into an agreement to acquire liquid handling consumables firm Ritter and its affiliates for approximately $1.05 billion in an...
Avantor expands its innovation center for bioprocessing
Avantor is increasing its investment in bioprocessing infrastructure by expanding its innovation center in Bridgewater, NJ.

Copyright © 2021 scienceboard.net


Conferences
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter